Minimal Information About an Immuno-Peptidomics Experiment (MIAIPE).

Autor: Lill JR; Department of Microchemistry, Proteomics and Lipidomics, Genentech Inc., 1 DNA Way, South San Francisco, CA, 94080, USA., van Veelen PA; Center for Proteomics and Metabolomics, Leiden University Medical Center, Albinusdreef 2, 2333, ZA Leiden, The Netherlands., Tenzer S; Institute for Immunology, University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstr. 1, 55131, Mainz, Germany., Admon A; Faculty of Biology, Technion-Israel Institute of Technology, Haifa, 3200003, Israel., Caron E; Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, 8093, Zurich, Switzerland., Elias JE; Department of Chemical and Systems Biology, Stanford University, Stanford, CA, 94305, USA., Heck AJR; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Science4Life, Utrecht University, Padualaan 8, 3584, CH Utrecht, The Netherlands.; Netherlands Proteomics Centre, Padualaan 8, 3584, CH Utrecht, The Netherlands., Marcilla M; Proteomics Unit, Spanish National Biotechnology Centre, Madrid, 28049, Spain., Marino F; Ludwig Institute for Cancer Research, University of Lausanne, 1066, Epalinges, Switzerland.; Department of Oncology, University of Lausanne, 1015, Lausanne, Switzerland., Müller M; Vital IT, Swiss Institute of Bioinformatics, 1015, Lausanne, Switzerland., Peters B; La Jolla Institute for Allergy and Immunology, Division of Vaccine Discovery, La Jolla, CA, 92037, USA., Purcell A; Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, 3800, Australia., Sette A; La Jolla Institute for Allergy and Immunology, Division of Vaccine Discovery, La Jolla, CA, 92037, USA.; University of California, La Jolla, CA, 92093, USA., Sturm T; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Science4Life, Utrecht University, Padualaan 8, 3584, CH Utrecht, The Netherlands.; Netherlands Proteomics Centre, Padualaan 8, 3584, CH Utrecht, The Netherlands., Ternette N; The Jenner Institute, Target Discovery Institute Mass Spectrometry Laboratory, University of Oxford, Oxford, OX3 7FZ, UK., Vizcaíno JA; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SD, UK., Bassani-Sternberg M; Ludwig Institute for Cancer Research, University of Lausanne, 1066, Epalinges, Switzerland.; Department of Oncology, University of Lausanne, 1015, Lausanne, Switzerland.
Jazyk: angličtina
Zdroj: Proteomics [Proteomics] 2018 Jun; Vol. 18 (12), pp. e1800110.
DOI: 10.1002/pmic.201800110
Abstrakt: Minimal information about an immuno-peptidomics experiment (MIAIPE) is an initiative of the members of the Human Immuno-Peptidome Project (HIPP), an international program organized by the Human Proteome Organization (HUPO). The aim of the MIAIPE guidelines is to deliver technical guidelines representing the minimal information required to sufficiently support the evaluation and interpretation of immunopeptidomics experiments. The MIAIPE document has been designed to report essential information about sample preparation, mass spectrometric measurement, and associated mass spectrometry (MS)-related bioinformatics aspects that are unique to immunopeptidomics and may not be covered by the general proteomics MIAPE (minimal information about a proteomics experiment) guidelines.
(© 2018 The Authors. Proteomics Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.)
Databáze: MEDLINE
Externí odkaz: